Financiën Novo Nordisk A/S

Aandelen

NOVO B

DK0062498333

Farmaceutische producten

Beurs gesloten - Nasdaq Copenhagen Andere beurzen 17:20:00 06-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
785,50 ^DKK	+1,88%		+3,72%	+12,52%

06/12	De voorgestelde overname van Catalent door Novo Holdings krijgt groen licht van de Europese Commissie	MT
06/12	De overname van Catalent door Novo Holdings ter waarde van $16,5 miljard wordt door de EU antitrust goedgekeurd	RE

Voorlopige winst- en verliesrekening: Novo Nordisk A/S

income-statement-evolution-chart NOVO-NORDISK-A-S

Fiscaal tijdperk: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
Omzet ¹	122.021	126.946	140.800	176.954	232.261	286.781	345.071	404.952
Variatie	-	4,04%	10,91%	25,68%	31,26%	23,47%	20,33%	17,35%
EBITDA ¹	58.144	59.879	64.669	82.171	111.987	142.068	174.093	207.312
Variatie	-	2,98%	8%	27,06%	36,29%	26,86%	22,54%	19,08%
Bedrijfsresultaat (EBIT) ¹	52.483	54.126	58.644	74.809	102.574	127.470	158.717	187.914
Variatie	-	3,13%	8,35%	27,56%	37,11%	24,27%	24,51%	18,4%
Betaalde rente ¹	-3.930	-996	436	-5.747	2.100	-104,6	-1.823	-884,4
Resultaat voor belastingen (EBT) ¹	48.553	53.130	59.080	69.062	104.674	127.203	156.987	187.649
Variatie	-	9,43%	11,2%	16,9%	51,57%	21,52%	23,42%	19,53%
Nettowinst (verlies) ¹	38.951	42.138	47.757	55.525	83.683	101.241	125.215	149.221
Variatie	-	8,18%	13,33%	16,27%	50,71%	20,98%	23,68%	19,17%
Datum van publicatie	05-02-20	03-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹DKK in Miljoen

Geschatte gegevens

Fiscaal tijdperk: Dezember	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Omzet ¹	32.417	33.875	30.006	30.927	32.138	33.804	33.041	35.622	38.333	42.301	41.265	45.566	48.092	53.367	54.300	58.731	65.863	65.349	68.060	71.311	81.326	79.926	80.975	83.684	90.806
Variatie	-	4,5%	-11,42%	3,07%	3,92%	5,18%	-2,26%	7,81%	7,61%	10,35%	-2,45%	10,42%	5,54%	10,97%	1,75%	8,16%	12,14%	-0,78%	4,15%	4,78%	14,04%	-1,72%	1,31%	3,35%	8,51%
EBITDA ¹	13.271	17.388	14.996	14.938	12.557	16.359	15.996	16.598	15.716	20.797	20.027	22.225	19.122	26.726	26.065	29.438	29.758	34.760	34.779	35.972	35.144	37.721	45.048	42.416	45.093
Variatie	-	31,02%	-13,76%	-0,39%	-15,94%	30,28%	-2,22%	3,76%	-5,31%	32,33%	-3,7%	10,98%	-13,96%	39,77%	-2,47%	12,94%	1,09%	16,81%	0,05%	3,43%	-2,3%	7,33%	19,42%	-5,84%	6,31%
Bedrijfsresultaat (EBIT) ¹	11.873	16.302	13.838	12.808	11.178	14.982	14.779	15.249	13.634	19.147	18.391	20.184	17.087	25.007	23.888	26.913	26.766	31.846	25.934	33.822	34.769	34.364	37.902	40.154	42.301
Variatie	-	37,3%	-15,11%	-7,44%	-12,73%	34,03%	-1,35%	3,18%	-10,59%	40,44%	-3,95%	9,75%	-15,34%	46,35%	-4,47%	12,66%	-0,55%	18,98%	-18,56%	30,42%	2,8%	-1,16%	10,3%	5,94%	5,35%
Charge d'intérêts ¹	-794	-1.281	-422	-	824	956	138	-137	-521	-1.228	-1.596	-2.152	-771	-270	-	-	-	72	-602	562	-136,7	-1.162	-916	-775	-725
Resultaat voor belastingen (EBT) ¹	11.079	15.021	13.416	12.691	12.002	15.938	14.917	15.112	13.113	17.919	16.795	18.032	16.316	24.737	24.254	28.063	27.620	31.918	25.332	34.384	34.418	32.846	36.915	40.920	42.752
Variatie	-	35,58%	-10,69%	-5,4%	-5,43%	32,79%	-6,41%	1,31%	-13,23%	36,65%	-6,27%	7,37%	-9,52%	51,61%	-1,95%	15,7%	-1,58%	15,56%	-20,63%	35,73%	0,1%	-4,57%	12,39%	10,85%	4,48%
Nettowinst (verlies) ¹	8.717	11.897	10.625	10.298	9.318	12.623	12.123	12.119	10.892	14.210	13.318	14.405	13.592	19.814	19.428	22.478	21.963	25.407	20.050	27.301	27.647	28.254	29.372	32.016	32.292
Variatie	-	36,48%	-10,69%	-3,08%	-9,52%	35,47%	-3,96%	-0,03%	-10,12%	30,46%	-6,28%	8,16%	-5,64%	45,78%	-1,95%	15,7%	-2,29%	15,68%	-21,08%	36,16%	1,27%	2,2%	3,95%	9,01%	0,86%
Datum van publicatie	05-02-20	06-05-20	06-08-20	30-10-20	03-02-21	05-05-21	04-08-21	03-11-21	02-02-22	29-04-22	03-08-22	02-11-22	01-02-23	04-05-23	10-08-23	02-11-23	31-01-24	02-05-24	07-08-24	06-11-24	-	-	-	-	-

¹DKK in Miljoen

Geschatte gegevens

Balansprognose: Novo Nordisk A/S

balance-sheet-analysis-chart NOVO-NORDISK-A-S

Fiscaal tijdperk: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
Nettoschuld ¹	-10.992	-2.401	9.160	2.210	-3.224	17.726	-468	-17.809
Variatie	-	-121,84%	281,51%	-75,87%	-245,88%	449,81%	-102,64%	-3.905,34%
Datum van publicatie	05-02-20	03-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹DKK in Miljoen

Geschatte gegevens

Verwachte kasstroom: Novo Nordisk A/S

Fiscaal tijdperk: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	8.932	5.825	6.335	12.146	25.806	45.159	44.619	44.297
Variatie	-	-34,79%	8,76%	91,73%	112,47%	74,99%	-1,2%	-0,72%
Vrije kasstroom (FCF) ¹	34.451	28.565	29.319	57.362	68.326	68.190	94.607	120.345
Variatie	-	-17,09%	2,64%	95,65%	19,11%	-0,2%	38,74%	27,2%
Datum van publicatie	05-02-20	03-02-21	02-02-22	01-02-23	31-01-24	-	-	-

¹DKK in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Novo Nordisk A/S

Fiscaal tijdperk: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
Winstgevendheid
EBITDA-marge (%)	47,65%	47,17%	45,93%	46,44%	48,22%	49,54%	50,45%	51,19%
EBIT-marge (%)	43,01%	42,64%	41,65%	42,28%	44,16%	44,45%	46%	46,4%
EBT-marge (%)	39,79%	41,85%	41,96%	39,03%	45,07%	44,36%	45,49%	46,34%
Nettomarge (%)	31,92%	33,19%	33,92%	31,38%	36,03%	35,3%	36,29%	36,85%
FCF-marge (%)	28,23%	22,5%	20,82%	32,42%	29,42%	23,78%	27,42%	29,72%
Vrije kasstroom/nettoresultaat (%)	88,45%	67,79%	61,39%	103,31%	81,65%	67,35%	75,56%	80,65%
Winstgevendheid
ROA	32,96%	31,15%	28,14%	25,48%	30,12%	26,86%	28,75%	30,64%
ROE	71,19%	69,7%	71,24%	72%	88,07%	82,3%	77,04%	72,63%
Financiële gezondheid
Hefboom (schuld/ebitda)	-	-	0,14x	0,03x	-	0,12x	-	-
Schuld/vrije kasstroom	-	-	0,31x	0,04x	-	0,26x	-	-
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	7,32%	4,59%	4,5%	6,86%	11,11%	15,75%	12,93%	10,94%
CAPEX / EBITDA (%)	15,36%	9,73%	9,8%	14,78%	23,04%	31,79%	25,63%	21,37%
CAPEX / FCF (%)	25,93%	20,39%	21,61%	21,17%	37,77%	66,23%	47,16%	36,81%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	9,837	11,1	11,94	17,36	24,23	23,94	29,71	34,99
Variatie	-	12,85%	7,57%	45,37%	39,6%	-1,21%	24,09%	17,78%
Dividend per aandeel ¹	4,175	4,55	5,2	6,2	9,4	11,27	14,62	17,68
Variatie	-	8,98%	14,29%	19,23%	51,61%	19,91%	29,74%	20,9%
Nettoactief per aandeel ¹	12,21	13,47	15,31	18,31	23,77	32,09	42,87	54,43
Variatie	-	10,32%	13,65%	19,56%	29,84%	34,98%	33,61%	26,96%
WPA ¹	8,19	9,005	10,37	12,22	18,62	22,6	28,4	34,24
Variatie	-	9,95%	15,16%	17,84%	52,37%	21,38%	25,65%	20,57%
Aantal aandelen (in duizend)	4.703.720	4.624.923	4.557.801	4.517.704	4.458.288	4.424.320	4.424.320	4.424.320
Datum van publicatie	05-02-20	03-02-21	02-02-22	01-02-23	31-01-24	-	-	-